These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26177737)

  • 1. Prediction of individual genetic risk to prostate cancer using a polygenic score.
    Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai ZS; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubiński J; Kluźniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lin HY; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; ; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; ; Gronberg H; Wiklund F
    Prostate; 2015 Sep; 75(13):1467-74. PubMed ID: 26177737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
    Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
    Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
    Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
    Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
    Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
    Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
    Byrne L; Toland AE
    Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
    Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L
    J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.
    Macinnis RJ; Antoniou AC; Eeles RA; Severi G; Al Olama AA; McGuffog L; Kote-Jarai Z; Guy M; O'Brien LT; Hall AL; Wilkinson RA; Sawyer E; Ardern-Jones AT; Dearnaley DP; Horwich A; Khoo VS; Parker CC; Huddart RA; Van As N; McCredie MR; English DR; Giles GG; Hopper JL; Easton DF
    Genet Epidemiol; 2011 Sep; 35(6):549-56. PubMed ID: 21769933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men.
    Oh JJ; Kim E; Woo E; Song SH; Kim JK; Lee H; Lee S; Hong SK; Byun SS
    Front Oncol; 2020; 10():583625. PubMed ID: 33194723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk prediction using a polygenic risk score.
    Sipeky C; Talala KM; Tammela TLJ; Taari K; Auvinen A; Schleutker J
    Sci Rep; 2020 Oct; 10(1):17075. PubMed ID: 33051487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
    Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
    Nat Commun; 2018 Nov; 9(1):4616. PubMed ID: 30397198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
    Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; Cancer BioResource AP; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; Gago-Dominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Am J Hum Genet; 2023 Jul; 110(7):1200-1206. PubMed ID: 37311464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.
    Wu C; Zhu J; King A; Tong X; Lu Q; Park JY; Wang L; Gao G; Deng HW; Yang Y; Knudsen KE; Rebbeck TR; Long J; Zheng W; Pan W; Conti DV; Haiman CA; Wu L
    Cancer Commun (Lond); 2021 Dec; 41(12):1387-1397. PubMed ID: 34520132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
    Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
    PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unidentified genetic variants influence pancreatic cancer risk: an analysis of polygenic susceptibility in the PanScan study.
    Pierce BL; Tong L; Kraft P; Ahsan H
    Genet Epidemiol; 2012 Jul; 36(5):517-24. PubMed ID: 22644738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
    Kader AK; Sun J; Reck BH; Newcombe PJ; Kim ST; Hsu FC; D'Agostino RB; Tao S; Zhang Z; Turner AR; Platek GT; Spraggs CF; Whittaker JC; Lane BR; Isaacs WB; Meyers DA; Bleecker ER; Torti FM; Trent JM; McConnell JD; Zheng SL; Condreay LD; Rittmaster RS; Xu J
    Eur Urol; 2012 Dec; 62(6):953-61. PubMed ID: 22652152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment.
    Yu H; Shi Z; Lin X; Bao Q; Jia H; Wei J; Helfand BT; Zheng SL; Duggan D; Lu D; Mo Z; Xu J
    Prostate; 2020 Jan; 80(1):83-87. PubMed ID: 31634418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
    Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J
    Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
    Thomas M; Sakoda LC; Hoffmeister M; Rosenthal EA; Lee JK; van Duijnhoven FJB; Platz EA; Wu AH; Dampier CH; de la Chapelle A; Wolk A; Joshi AD; Burnett-Hartman A; Gsur A; Lindblom A; Castells A; Win AK; Namjou B; Van Guelpen B; Tangen CM; He Q; Li CI; Schafmayer C; Joshu CE; Ulrich CM; Bishop DT; Buchanan DD; Schaid D; Drew DA; Muller DC; Duggan D; Crosslin DR; Albanes D; Giovannucci EL; Larson E; Qu F; Mentch F; Giles GG; Hakonarson H; Hampel H; Stanaway IB; Figueiredo JC; Huyghe JR; Minnier J; Chang-Claude J; Hampe J; Harley JB; Visvanathan K; Curtis KR; Offit K; Li L; Le Marchand L; Vodickova L; Gunter MJ; Jenkins MA; Slattery ML; Lemire M; Woods MO; Song M; Murphy N; Lindor NM; Dikilitas O; Pharoah PDP; Campbell PT; Newcomb PA; Milne RL; MacInnis RJ; Castellví-Bel S; Ogino S; Berndt SI; Bézieau S; Thibodeau SN; Gallinger SJ; Zaidi SH; Harrison TA; Keku TO; Hudson TJ; Vymetalkova V; Moreno V; Martín V; Arndt V; Wei WQ; Chung W; Su YR; Hayes RB; White E; Vodicka P; Casey G; Gruber SB; Schoen RE; Chan AT; Potter JD; Brenner H; Jarvik GP; Corley DA; Peters U; Hsu L
    Am J Hum Genet; 2020 Sep; 107(3):432-444. PubMed ID: 32758450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.